A. Bibby

A New Calcipotriol/Betamethasone Dipropionate Formulation (Daivobet<sup>TM</sup>) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

Roland Kaufmann, A. Bibby, Robert Bissonnette et al. · Dermatology · 2002 · 163 citations

Pharmacy, Dermatology, Pharmacotherapy +11

A New Calcipotriol/Betamethasone Formulation with Rapid Onset of Action was Superior to Monotherapy with Betamethasone Dipropionate or Calcipotriol in Psoriasis Vulgaris

W.S. Douglas, Yves Poulin, J. Decroix et al. · Acta Dermato Venereologica · 2002 · 159 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +10

A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet^®/Daivobet^®/Taclonex^®) in the treatment of psoriasis vulgaris

Knud Kragballe, Joar Austad, Larry D. Barnes et al. · British Journal of Dermatology · 2006 · 138 citations

Pharmacy, Dermatology, Pharmacotherapy +9

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

Knud Kragballe, Joar Austad, L. Barnes et al. · Dermatology · 2006 · 74 citations

Pharmacy, Dermatology, Pharmacotherapy +10

A calcipotriene/betamethasone dipropionate two‐compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8‐week, double‐blind phase of a clinical trial

Stephen K. Tyring, Natalia Mendoza, Melanie Appell et al. · International Journal of Dermatology · 2010 · 45 citations

Pharmacy, Dermatology, Pharmacotherapy +8